carvedilol has been researched along with Cholangitis, Sclerosing in 1 studies
Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horsley-Silva, JL | 1 |
| Dow, EN | 1 |
| Menias, CO | 1 |
| Smith, ML | 1 |
| Carballido, EM | 1 |
| Lindor, KD | 1 |
| Vargas, HE | 1 |
1 other study available for carvedilol and Cholangitis, Sclerosing
| Article | Year |
|---|---|
Docetaxel Induced Sclerosing Cholangitis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Antineo | 2015 |